A study on steroids as an additional drug in the treatment of long duration migraine headache.
- Conditions
- Health Condition 1: G437- Chronic migraine without aura
- Registration Number
- CTRI/2019/01/017326
- Lead Sponsor
- ational Institute of Mental Health and NeuroSciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Chronic migraine patients meeting the criteria according to ICHD-3 (2013) on prophylaxis for a period of at least 3months.
-Medical conditions that increase the risk of steroid administration like-Diabetes Mellitus (operationally defined as FBS >140; PPBS >200mg/dl), Impaired glucose tolerance (postprandial glucose levels of 140 to 199 mg per dL), Impaired fasting glucose (glucose levels of 100 to 125 mg per dL in fasting patients), Active infections, Hypertension( >140/90mmHg),Chronic co-morbidities that might be affected by steroids or would make changes in the clinical or biochemical values that would likely unmask the blinding. Diagnosis of secondary headache, Complicated migraine, Beck Depression Inventory (BDI) >24 (moderate depression)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method